GIM
HOLX

Glenmede Investment Management’s Hologic HOLX Stock Holding History

Glenmede Investment Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$312K Sell
4,616
-205
-4% -$13.6K ﹤0.01% 1110
2025
Q2 		$314K Buy
+4,821
New +$289K ﹤0.01% 1090

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Glenmede Investment Management's HOLX Position: Q3 2025 in Review

Glenmede Investment Management reduced its Hologic (HOLX) stake by 4.3% in Q3 2025, selling an estimated $13.6K and leaving 4,616 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Glenmede Investment Management first reported a position in HOLX in Q2 2025 and has held it in 2 quarters since. The position peaked at $314K in Q2 2025. 739 funds tracked by Wall St. Rank hold HOLX as of Q3 2025.

  • Glenmede Investment Management held 4,616 shares of Hologic worth $312K as of Q3 2025.
  • Glenmede Investment Management sold 205 Hologic shares in Q3 2025, an estimated $13.6K.
  • Hologic made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1110 holding.
  • Glenmede Investment Management first reported a position in Hologic in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Hologic position peaked at $314K in Q2 2025.
  • 739 funds tracked by Wall St. Rank held Hologic as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.